These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
591 related articles for article (PubMed ID: 20542809)
21. Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform. Jaschke B; Michaelis C; Milz S; Vogeser M; Mund T; Hengst L; Kastrati A; Schömig A; Wessely R Cardiovasc Res; 2005 Dec; 68(3):483-92. PubMed ID: 16111664 [TBL] [Abstract][Full Text] [Related]
22. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis. Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742 [TBL] [Abstract][Full Text] [Related]
23. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation. Francis DJ; Parish CR; McGarry M; Santiago FS; Lowe HC; Brown KJ; Bingley JA; Hayward IP; Cowden WB; Campbell JH; Campbell GR; Chesterman CN; Khachigian LM Circ Res; 2003 May; 92(8):e70-7. PubMed ID: 12690039 [TBL] [Abstract][Full Text] [Related]
24. Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma. Joner M; Morimoto K; Kasukawa H; Steigerwald K; Merl S; Nakazawa G; John MC; Finn AV; Acampado E; Kolodgie FD; Gold HK; Virmani R Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1960-6. PubMed ID: 18688017 [TBL] [Abstract][Full Text] [Related]
25. Early activation of internal medial smooth muscle cells in the rabbit aorta after mechanical injury: relationship with intimal thickening and pharmacological applications. Louis H; Lacolley P; Kakou A; Cattan V; Daret D; Safar M; Bonnet J; Daniel Lamazière JM Clin Exp Pharmacol Physiol; 2006; 33(1-2):131-8. PubMed ID: 16445712 [TBL] [Abstract][Full Text] [Related]
26. CREG promotes a mature smooth muscle cell phenotype and reduces neointimal formation in balloon-injured rat carotid artery. Han Y; Deng J; Guo L; Yan C; Liang M; Kang J; Liu H; Graham AM; Li S Cardiovasc Res; 2008 Jun; 78(3):597-604. PubMed ID: 18267954 [TBL] [Abstract][Full Text] [Related]
27. Local administration of NF-kappa B decoy oligonucleotides to prevent restenosis after balloon angioplasty: an experimental study in New Zealand white rabbits. Kalinowski M; Viehofer K; Hamann C; Barry JJ; Kleb B; Klose KJ; Wagner HJ; Alfke H Cardiovasc Intervent Radiol; 2005; 28(3):331-7. PubMed ID: 15886949 [TBL] [Abstract][Full Text] [Related]
28. Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation. Torella D; Curcio A; Gasparri C; Galuppo V; De Serio D; Surace FC; Cavaliere AL; Leone A; Coppola C; Ellison GM; Indolfi C Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2935-43. PubMed ID: 17293493 [TBL] [Abstract][Full Text] [Related]
29. Effects of tacrolimus or sirolimus on proliferation of vascular smooth muscle and endothelial cells. Matter CM; Rozenberg I; Jaschko A; Greutert H; Kurz DJ; Wnendt S; Kuttler B; Joch H; Grünenfelder J; Zünd G; Tanner FC; Lüscher TF J Cardiovasc Pharmacol; 2006 Dec; 48(6):286-92. PubMed ID: 17204907 [TBL] [Abstract][Full Text] [Related]
30. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo. Hacker TA; Griffin MO; Guttormsen B; Stoker S; Wolff MR J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129 [TBL] [Abstract][Full Text] [Related]
31. Heparan sulfate side chains have a critical role in the inhibitory effects of perlecan on vascular smooth muscle cell response to arterial injury. Gotha L; Lim SY; Osherov AB; Wolff R; Qiang B; Erlich I; Nili N; Pillarisetti S; Chang YT; Tran PK; Tryggvason K; Hedin U; Tran-Lundmark K; Advani SL; Gilbert RE; Strauss BH Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H337-45. PubMed ID: 24858854 [TBL] [Abstract][Full Text] [Related]